Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Magnesium Oxide Monohydrate for Nocturnal Leg Cramps (MgNLC)

This study has been terminated.
(Blinded interim analysis was presented to an independent data monitoring committee. Recommendation, submitted April 1, 2014, was early termination for futility.)
Sponsor:
Information provided by (Responsible Party):
Uzi Milman, Clalit Health Services
ClinicalTrials.gov Identifier:
NCT01709968
First received: October 17, 2012
Last updated: January 19, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2014
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)